NLRP3 and atherosclerosis: The vital role of pyroptosis in the pathogenesis of atherosclerosis has generated a few specific inhibitors or agents that target bioactive substances such as NLRP3, caspase-1, caspase-4/5/11, GSDMD, and other candidates in relation to pyroptosis pathway [7][81][84].